Abstract:A total of 60 breast cancer (BC) tissues and adjacent healthy tissues from patients who underwent surgery in Renmin Hospital of Wuhan University were collected for analysis in the present study. Results from reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) demonstrated that, compared with the adjacent healthy tissues, the expression levels of microRNA (miR)‑142‑5p were significantly elevated in BC tissues. Bioinformatics analysis was performed using TargetScan for the prediction of potential target sites that matched the seed region of miR‑142‑5p; phosphatase and tensin homolog (PTEN) exhibited the highest score and was selected for further analysis. Results of RT‑qPCR analysis demonstrated that, compared with the adjacent healthy tissues, the mRNA expression levels of PTEN were significantly decreased in breast cancer tissues. miR‑142‑5p and PTEN expression levels were positively and negatively associated, respectively, with patient tumor size and metastasis. MDA‑MB‑231 cells were divided into three groups including the Control group, the miR‑NC inhibitor group and the miR‑142‑5p inhibitor group. As for alterations in cell behavior, including cell viability and cell apoptosis, and protein expression levels, there were no significant differences between Control and miR‑NC inhibitor groups. MTT assay results revealed that, compared with Control and miR‑NC inhibitor groups, miR‑142‑5p inhibitor reduced MDA‑MB‑231 cell proliferation. Flow cytometric analysis demonstrated that, compared with Control and miR‑NC inhibitor groups, miR‑142‑5p inhibitor treatment induced MDA‑MB‑231 cell apoptosis. Western blotting results demonstrated that, compared with Control and miR‑NC inhibitor groups, miR‑142‑5p inhibitor treatment significantly increased the expression of PTEN, reduced the activation of phosphatidylinositol‑4,5‑bisphosphate 3‑kinase/RACα serine/threonine‑protein kinase signaling. Finally, PTEN was demonstrated to interact with miR‑142‑5p from the results of dual‑luciferase reporter assay in the present study. The findings of the present study suggested that miR‑142‑5p may be a potential therapeutic target for the future investigations and insights for breast cancer.

MicroRNA-1297 Downregulation Inhibits Breast Cancer Cell Epithelial-Mesenchymal Transition and Proliferation in a FA2H-dependent Manner

MicroRNA-1298-5p Inhibits the Tumorigenesis of Breast Cancer by Targeting E2F1

MicroRNA-1297 Contributes to Tumor Growth of Human Breast Cancer by Targeting PTEN/PI3K/AKT Signaling

MiR-512-3p Expression Pattern and Function in Breast Cancer

miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer

Downregulation of Mir-129-2 by Promoter Hypermethylation Regulates Breast Cancer Cell Proliferation and Apoptosis.

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Mirna-1260B Promotes Breast Cancer Cell Migration and Invasion by Downregulating CCDC134

MiR‐429 Suppresses Proliferation and Invasion of Breast Cancer Via Inhibiting the Wnt/β‐catenin Signaling Pathway

Promotional Effect of Microrna-194 on Breast Cancer Cells Via Targeting F-box/WD Repeat-Containing Protein 7.

[The Down-Regulation of Mir-129 in Breast Cancer and Its Effect on Breast Cancer Migration and Motility].

MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells Via RRM2-Dependent MAPK Signaling Pathway

MiR-129-2 Weakens Proliferation and Promotes Apoptosis of Liver Cancer Cells by Suppressing the Wnt Signaling Pathway

Methylation-mediated Repression of Microrna-129-2 Suppresses Cell Aggressiveness by Inhibiting High Mobility Group Box 1 in Human Hepatocellular Carcinoma.

A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis

MicroRNA-132-3p Inhibits Tumor Malignant Progression by Regulating Lysosomal-Associated Protein Transmembrane 4 Beta in Breast Cancer

MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7

MicroRNA-1296 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting SRPK1-mediated PI3K/AKT Pathway

LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis

MicroRNA‑142‑5p Modulates Breast Cancer Cell Proliferation and Apoptosis by Targeting Phosphatase and Tensin Homolog

Mir-29B-3p Promotes Progression of MDA-MB-231 Triple-Negative Breast Cancer Cells Through Downregulating TRAF3.